Literature DB >> 17623734

Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France.

M Debouverie1, S Pittion-Vouyovitch, S Louis, T Roederer, F Guillemin.   

Abstract

This study aims to describe the prevalence and incidence rates of multiple sclerosis (MS) in Lorraine, France, and its secular trend from 1990 to 2002. Cases were sourced from the regional network of MS healthcare workers in the Lorraine region and include all cases with definite or probable MS according to Poser's criteria. We identified 2718 patients with MS on 31 December 2004. The prevalence rate was 120/100,000 (95% confidence interval [CI]: 119-121). Between 1990 and 2002, the average age- and sex-adjusted annual incidence rate was 5.5/100,000 (95% CI: 4.4-6.6). During this same period, there was a significant increase in overall incidence in women but not in men. The mean age at MS onset, disability score five years after onset, number of relapses during the first five years, and proportion of first attack with sequelae or polysymptomatic symptoms were not significantly different between each annual cohort during the study period. The prevalence and incidence rates of MS we found in our study were higher than in previous studies in France. The increase in incidence of MS between 1990 and 2002, mostly in women, was not related to better ascertainment of patients with mild disability.

Entities:  

Mesh:

Year:  2007        PMID: 17623734     DOI: 10.1177/1352458507077938

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  21 in total

1.  Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way.

Authors:  Monan Angela Zhang; Dorothy Rego; Marina Moshkova; Hania Kebir; Andrzej Chruscinski; Hoangkim Nguyen; Rainer Akkermann; Frank Z Stanczyk; Alexandre Prat; Lawrence Steinman; Shannon E Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-30       Impact factor: 11.205

2.  Association of UV radiation with multiple sclerosis prevalence and sex ratio in France.

Authors:  S-M Orton; L Wald; C Confavreux; S Vukusic; J P Krohn; S V Ramagopalan; B M Herrera; A D Sadovnick; G C Ebers
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

3.  Sex ratio in multiple sclerosis mortality over 65 years; an age-period-cohort analysis in Norway.

Authors:  Ola Nakken; Jonas Christoffer Lindstrøm; Trygve Holmøy
Journal:  J Neurol       Date:  2018-03-21       Impact factor: 4.849

Review 4.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

5.  Sex differences in resting-state functional connectivity in multiple sclerosis.

Authors:  K A Koenig; M J Lowe; J Lin; K E Sakaie; L Stone; R A Bermel; E B Beall; S M Rao; B D Trapp; M D Phillips
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

6.  Increasing incidence of multiple sclerosis among women in Buenos Aires: a 22 year health maintenance organization based study.

Authors:  E Cristiano; L Patrucco; J Miguez; D Giunta; J Peroni; J I Rojas
Journal:  Neurol Sci       Date:  2016-06-23       Impact factor: 3.307

Review 7.  Apparent changes in the epidemiology and severity of multiple sclerosis.

Authors:  Nils Koch-Henriksen; Melinda Magyari
Journal:  Nat Rev Neurol       Date:  2021-09-28       Impact factor: 42.937

8.  Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.

Authors:  Seyed Aidin Sajedi; Fahimeh Abdollahi
Journal:  BMC Neurol       Date:  2012-09-24       Impact factor: 2.474

Review 9.  Gender and sex hormones in multiple sclerosis pathology and therapy.

Authors:  Arnaud Nicot
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  Geographical variations in sex ratio trends over time in multiple sclerosis.

Authors:  Maria Trojano; Guglielmo Lucchese; Giusi Graziano; Bruce V Taylor; Steve Simpson; Vito Lepore; Francois Grand'maison; Pierre Duquette; Guillermo Izquierdo; Pierre Grammond; Maria Pia Amato; Roberto Bergamaschi; Giorgio Giuliani; Cavit Boz; Raymond Hupperts; Vincent Van Pesch; Jeannette Lechner-Scott; Edgardo Cristiano; Marcela Fiol; Celia Oreja-Guevara; Maria Laura Saladino; Freek Verheul; Mark Slee; Damiano Paolicelli; Carla Tortorella; Mariangela D'Onghia; Pietro Iaffaldano; Vita Direnzo; Helmut Butzkueven
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.